SCHEMBL2442929

SCHEMBL2442929

O=[C]CCCCC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1702085 0.97 TSHR (0.63)
SCHEMBL374773 0.97 TSHR (0.63)
SCHEMBL7382880 0.97 TSHR (0.63)
SCHEMBL3972155 0.97 TSHR (0.63)
SCHEMBL3980051 0.97 TSHR (0.63)
SCHEMBL1654498 0.97 TSHR (0.63)
SCHEMBL6539108 0.97 TSHR (0.63)
SCHEMBL970516 0.97 TSHR (0.63)
SCHEMBL1401237 0.97 TSHR (0.63)
SCHEMBL7292218 0.97 TSHR (0.63)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230102146-A1 MULTI-TARGET TYROSINE KINASE INHIBITOR SHENZHEN NEPTUNUS PHARMACEUTICAL RESEARCH INSTITUTE CO., LTD. (CN) 2023-03-30 US claimed
EP-4108666-A1 MULTI-TARGET TYROSINE KINASE INHIBITOR Shenzhen Neptunus Pharmaceutical Research Institute Co., Ltd. (CN) 2022-12-28 EP claimed
CN-113336768-B Multi-target tyrosine kinase inhibitor 深圳海王医药科技研究院有限公司 2022-08-19 CN claimed
CN-113336768-A Multi-target tyrosine kinase inhibitor 深圳海王医药科技研究院有限公司 2021-09-03 CN claimed
WO-2009111513-A1 ENGINEERED CO2 FIXING MICROORGANISMS PRODUCING CARBON-BASED PRODUCTS OF INTEREST JOULE BIOTECHNOLOGIES, INC. (US) 2009-09-11 WO claimed
US-5674467-A USED IN NMR DIAGNOSIS, RADIODIAGNOSIS OR RADIOTHERAPY INSTITUT FUR DIAGNOSTIKFORSCHUNG GMBH (DE) 1997-10-07 US claimed
EP-0333174-B1 Peptide compounds, processes for preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO (JP) 1996-05-08 EP claimed
US-5187156-A D-Tryptophan- and Phenylalanine-containing tripeptides as tachykinin antagonists; asthma FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-02-16 US claimed
EP-0333174-A2 Peptide compounds, processes for preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-09-20 EP claimed
EP-0312157-A2 Tetrapeptide renin inhibitors having a novel c-terminal amino acid MERCK & CO. INC. (US) 1989-04-19 EP claimed
US-4668781-A Ceph-3-one compounds and process for their manufacture CIBA-GEIGY CORPORATION (US) 1987-05-26 US claimed
US-20230102146-A1 MULTI-TARGET TYROSINE KINASE INHIBITOR SHENZHEN NEPTUNUS PHARMACEUTICAL RESEARCH INSTITUTE CO., LTD. (CN) 2023-03-30 US disclosed
EP-4108666-A1 MULTI-TARGET TYROSINE KINASE INHIBITOR Shenzhen Neptunus Pharmaceutical Research Institute Co., Ltd. (CN) 2022-12-28 EP disclosed
CN-113336768-B Multi-target tyrosine kinase inhibitor 深圳海王医药科技研究院有限公司 2022-08-19 CN disclosed
CN-113336768-A Multi-target tyrosine kinase inhibitor 深圳海王医药科技研究院有限公司 2021-09-03 CN disclosed
US-4152450-A 9-Amino-dibenzopyrans ELI LILLY AND COMPANY (US) 1979-05-01 US disclosed
US-4008313-A Novel corticoids SCHERING AKTIENGESELLSCHAFT (DT) 1977-02-15 US disclosed
US-4000275-A BENZIMIDAZO(2,1-B) QUINAZOLIN-12(6H)ONES ELI LILLY AND COMPANY (US) 1976-12-28 US disclosed
US-3987040-A 3-SUBSTITUTED METHYL-7-ACYLAMINO-7-METHOXY-2-CEPHEM-4-CARBOXYLIC ACID AND ITS ESTERS MERCK & CO., INC. (US) 1976-10-19 US disclosed
US-3936478-A Process for the preparation of desmosterol derivatives TEIJIN LIMITED (JA) 1976-02-03 US disclosed